Экстракорпоральный фотоферез в лечении реакции «транспл антат против хозяина»
https://doi.org/10.17650/1818-8346-2016-11-1-47-51
Аннотация
Экстракорпоральный фотоферез доказал свою практическую эффективность в лечении хронической реакции «трансплантат против хозяина» после аллогенной трансплантации гемопоэтических стволовых клеток и представляет собой альтернативу другим методам лечения. К его преимуществам относятся хорошая переносимость, отсутствие ограничений по возрасту, минимум инфекционных осложнений по сравнению с последствиями увеличения иммуносупрессии. Этот метод терапии дает реальное улучшение качества жизни.
Об авторах
И. В. ГузРоссия
П. Е. Трахтман
Россия
Список литературы
1. Hart J. W., Shiue L. H., Shpall E. J., Alousi A. M. Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol 2013;4(5):320–34.
2. Holler E. Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment. Best Pract Res Clin Haematol 2007;20(2):281–94.
3. Worel N., Leitner G. Clinical results of extracorporeal photopheresis. Transfus Med Hemother 2012;39(4):254–62.
4. Yoo E. K., Rook A. H., Elenitsas R. et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996;107(2):235–42.
5. Berger C. L., Xu A. L., Hanlon D. et al. Induction of human tumor-loaded dendritic cells. Int J Cancer 2001;91(4):438–47.
6. Knobler R., Berlin G., Calzavara-Pinton P. et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014;28 Suppl 1:1–37.
7. Edelson R. L. Photopheresis: a clinically relevant immunobiologic response modifier. Ann NY Acad Sci 1991;636:154–64.
8. Steinman R. M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191(3):411–6.
9. Stewart B. L., Storer B., Storek J. et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004;104(12):3501–6.
10. Lee S. J., Vogelsang G., Flowers M. E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9(4):215–33.
11. Carlens S., Ringden O., Remberger M. et al. Risk factors for chronic graft-versushost disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998;22(8):755–61.
12. Anasetti C., Logan B. R., Lee S. J. et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012;367(16):1487–96.
13. Owsianowski M., Gollnick H., Siegert W. et al. Successful treatment of chronic graftversus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994;14(5):845–8.
14. Flowers M. E., Inamoto Y., Carpenter P. A. et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011;117(11):3214–9.
15. Flowers M. E., Apperley J. F., van Besien K. et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008;112(7):2667–74.
16. Malik M. I., Litzow M., Hogan W. et al. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis. Blood Res 2014;49(2):100–6.
17. Hahn T., McCarthy P. L. Jr, Zhang M. J. et al. Risk factors for acute graft-versus-host disease after human leukocyte antigenidentical sibling transplants for adults with leukemia. J Clin Oncol 2008;26(35): 5728–34.
18. Bolaños-Meade J., Vogelsang G. B. Novel strategies for steroid-refractory acute graftversus-host disease. Curr Opin Hematol 2005;12(1):40–4.
19. Wolff D., Ayuk F., Elmaagacli A. et al. Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers. Biol Blood Marrow Transplant 2013;19(5):767–76.
20. Deeg H. J. How I treat refractory acute GVHD. Blood 2007;109(10):4119–26.
21. Greinix H. T., Knobler R. M., Worel N. et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006;91(3):405–8.
22. Greinix H. T., Worel N., Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft- versus-host disease. Biol Blood Marrow Transplant 2010;16(12):1747–8.
23. Zhang H., Chen R., Cheng J. et al. Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD. Patient Prefer Adherence 2015;9:105–11.
24. Kanold J., Merlin E., Halle P. et al. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion 2007;47(12):2276–89.
25. Calore E., Calò A., Tridello G. et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant 2008;42(6):421–5.
26. Messina C., Locatelli F., Lanino E. et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003;122(1):118–27.
27. Klassen J. The role of photopheresis in the treatment of graft-versus-host disease. Curr Oncol 2010;17(2):55–8.
28. Couriel D., Hosing C., Saliba R. et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006;107(8):3074–80.
29. Foss F., Gorgun G., Miller K. Extracorporeal photopheresis in chronic graft-versushost disease. Bone Marrow Transplant 2002;29(9):719–25.
Рецензия
Для цитирования:
Гуз И.В., Трахтман П.Е. Экстракорпоральный фотоферез в лечении реакции «транспл антат против хозяина». Онкогематология. 2016;11(1):47-51. https://doi.org/10.17650/1818-8346-2016-11-1-47-51
For citation:
Guz I.V., Trachtman P.E. Extracorporeal photopheresis in the treatment of graft-versus-host disease. Oncohematology. 2016;11(1):47-51. (In Russ.) https://doi.org/10.17650/1818-8346-2016-11-1-47-51